Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By https://jonasjxip608930.digitollblog.com/36057956/tirzepatide-a-promising-new-treatment-for-obesity